Adaptive Biotechnologies
ADPT
#4738
Rank
HK$14.96 B
Marketcap
HK$97.21
Share price
-11.10%
Change (1 day)
52.07%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: HK$14.96 Billion

As of March 2026 Adaptive Biotechnologies has a market cap of HK$14.96 Billion. This makes Adaptive Biotechnologies the world's 4738th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$14.96 B-24.55%
2025HK$19.83 B175.26%
2024HK$7.20 B30.08%
2023HK$5.54 B-35.1%
2022HK$8.53 B-72.35%
2021HK$30.87 B-50.75%
2020HK$62.69 B114.83%
2019HK$29.18 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

HK$14.96 Billion
by Nasdaq info icon info icon
HK$14.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
HK$826.48 B 5,421.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
HK$18.30 B 22.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
HK$3.10 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
HK$15.82 B 5.72%๐Ÿ‡บ๐Ÿ‡ธ USA